New Drugs 2019
Tracking # 20-694937
Course overview
RX Objectives/NP For each of the drugs reviewed: 1. List the FDA approved indication(s), state the recommended dose(s), and discuss the evidence supporting the drug's approval and potential role(s) in therapy. 2.Describe significant side effects and drug interactions. Provide 2-3 patient counseling tips. For drugs listed in Tables 2 and 3: 3.List the generic/brand names, dosage form(s), FDA approved indication(s), and major safety concerns if discussed. 4. Describe a biosimilar product and how it differs from a generic product PHARMACY TECHNICIANS 1.For each of the drugs reviewed, state the generic name, brand name, FDA-approved indication(s), and usual dose. 2.For each of the drugs reviewed, describe common or serious side effects and significant drug interactions. 3.For drugs listed in Tables 2 and 3, state generic/brand names, dosage forms, FDA-approved indications, and major safety concerns if discussed. Describe the term biosimilar and interchangeability with reference products.
Subject areas
This course counts toward the state boards and subject areas below.
District of Columbia Board of Nursing
Certified Nurse Midwife
Clinical Nurse Specialist
Licensed Practical Nurse
Nurse Practitioner
Registered Nurse
Registered Nurse Anesthetist
Florida Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
Georgia Board of Nursing
Licensed Practical Nurse
Registered Professional Nurse
New Mexico Board of Nursing
Certified Registered Nurse Anesthetist
Clinical Nurse Specialist
South Carolina Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
Disclosure statements
Dr. Chan report no financial relationship with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) that appear in this issue.